Health Systems Face Marketing Crisis as Hospital-At-Home Proves Superior Outcomes Without Facility Walls

Health systems that moved acute care into patient homes saw lower emergency department visits and reduced in-hospital mortality, according to a 2026 study published in JAMA Network Open . For healthcare marketers, this validates a fundamental shift: the hospital room is no longer the gold standard care setting in the minds of patients or payers. Marketing strategies built around facility tours, bed counts, and brick-and-mortar proximity now compete against a care model that promises clinical outcomes without the hospital walls.

The study examined hospital-at-home programs where patients receive acute-level care in their residences instead of inpatient beds. Patients enrolled in these programs experienced fewer subsequent ED visits and lower mortality rates compared to traditional hospital admissions . The data arrives as Medicare expands reimbursement for hospital-at-home services and commercial payers follow suit, creating a reimbursement environment that rewards dispersed care delivery over centralized facilities.

"Patients with this ultra-rare type of cancer desperately need new treatment options," FDA Commissioner Marty Makary stated in May 2026, discussing the agency's accelerated approval pathways under the National Priority Voucher program . While Makary referenced rare disease treatment, his comment reflects the FDA's broader 2026 posture: regulatory frameworks now prioritize patient access and outcomes over traditional care settings. The same logic driving accelerated drug approvals — getting effective treatments to patients faster — now applies to care delivery models that keep patients out of hospitals entirely.

This matters for every healthcare marketer, not just those working with health systems operating hospital-at-home programs. Payers now have clinical evidence that home-based acute care reduces costly ED utilization and improves mortality outcomes. Patient acquisition strategies that emphasize hospital amenities — private rooms, advanced equipment, visitor policies — suddenly face a competitor that offers none of those things yet delivers superior outcomes. The brand promise shifts from "we have the best hospital" to "you don't need a hospital at all."

The Reimbursement Reality Reshaping Patient Acquisition

Medicare's expansion of hospital-at-home reimbursement in recent years created the financial foundation for these programs to scale. Commercial payers watched Medicare's lead and began contracting with health systems and specialized home care vendors to launch their own programs. The 2026 JAMA Network Open study provides the outcomes data payers needed to justify shifting more acute care out of facilities .

For marketers, this creates a patient acquisition paradox. Health systems spent decades building brand equity around their physical facilities — the new cancer center, the renovated maternity ward, the Level I trauma designation. Those investments remain clinically necessary for certain acuity levels, but the addressable patient population for facility-based care is shrinking. Hospital-at-home programs target conditions traditionally requiring multi-day inpatient stays: heart failure exacerbations, pneumonia, COPD flare-ups, certain post-surgical recovery periods.

The marketing playbook for facility-based care doesn't translate. Patients selecting hospital-at-home programs aren't comparing your hospital's cafeteria to the competitor's. They're evaluating whether your health system can deliver acute care safely in their living room. The trust signals shift from building tours and physician bios to response times, remote monitoring technology, and same-day clinician visits.

What Works When the Product Is Staying Home

Health systems marketing hospital-at-home programs face a consumer education challenge. Patients conditioned to believe "sick enough for hospital admission" means "must go to the hospital" need new mental models. The 2026 study's findings on reduced ED visits suggest hospital-at-home programs may improve outcomes partly by keeping patients in a managed care pathway rather than bouncing between home, ED, and readmission .

Effective marketing for these programs addresses three patient concerns explicitly:

The competitive advantage for hospital-at-home programs isn't clinical differentiation — the care protocols are largely standardized. It's operational execution and trust-building. Health systems that market 24/7 clinician availability, median response times under two hours, and readmission rates below national benchmarks will capture market share from competitors still marketing their buildings.

The ED Utilization Play That Payers Are Watching

The study's finding on reduced ED visits matters more to payers than to patients . Emergency departments represent uncontrolled costs — patients arrive without authorization, receive expensive workups, and often get admitted when outpatient management might have sufficed. Hospital-at-home programs give payers a managed alternative: acute care delivered by contracted clinicians following approved protocols at predictable costs.

For health systems, this creates a business development opportunity disguised as a marketing challenge. Payers want to reduce ED utilization without denying necessary care or creating access barriers that generate patient complaints. Hospital-at-home programs solve that problem, but only if patients know the programs exist and choose them over default ED visits.

Marketing must reach patients before the acute event. A heart failure patient who learns about hospital-at-home during a routine cardiology visit can call the program during their next exacerbation instead of dialing 911. That requires primary care and specialist practices to market the program as an acute care option, not an ancillary service. Physicians need talking points, waiting room signage, and after-visit summaries that list the hospital-at-home hotline prominently.

The payer story also matters for B2B marketing. Health systems pitching hospital-at-home programs to commercial payers and Medicare Advantage plans should lead with the ED utilization reduction. Payers don't care about patient satisfaction scores or brand perception. They care about total cost of care and avoidable acute events. A health system that can document 20% fewer ED visits among hospital-at-home patients versus matched controls has a compelling payer contract story.

Compliance and Patient Privacy in Distributed Care

Hospital-at-home programs create HIPAA compliance complexity that facility-based care avoids. Clinicians accessing patient homes use personal devices, home Wi-Fi networks, and telehealth platforms that may not meet facility-grade security standards. Marketing materials that promise "the same care you'd receive in the hospital" carry implicit privacy and security assurances that operations must deliver.

Health systems marketing these programs must address privacy explicitly, particularly for patients receiving behavioral health or substance use treatment at home. Marketing copy should specify that all clinicians follow HIPAA protocols, remote monitoring data is encrypted, and patients control which family members receive health information. These aren't differentiators — they're table stakes — but patients need reassurance.

State regulations on telehealth and home-based acute care vary significantly. Health systems operating hospital-at-home programs across multiple states must ensure marketing claims comply with each state's scope of practice rules, licensing requirements, and reimbursement policies. A program marketed identically in Ohio and Texas may face different regulatory constraints that affect which patients qualify and which services clinicians can deliver at home.

The 1ness Take

The 2026 JAMA Network Open study gives healthcare marketers permission to stop selling hospitals and start selling outcomes . For decades, health systems marketed their facilities as proxies for quality: more beds, newer equipment, prestigious certifications. Hospital-at-home programs strip away the facility and ask patients to trust clinical protocols and operational execution instead.

This forces a fundamental marketing question: what are you actually selling? If your brand promise centers on your building, your lobby, your private rooms — you're marketing a commodity that a growing segment of acute care patients no longer need. If your brand promise centers on outcomes, access, and coordinated care regardless of setting, you have a story that works whether the patient receives care in your hospital or their home.

Health systems should segment their acute care marketing into two distinct campaigns. Facility-based marketing continues for high-acuity patients who need ICU care, surgery, or interventional procedures. Hospital-at-home marketing targets the second tier: patients sick enough for admission but stable enough for home-based monitoring and treatment. These patients overlap significantly with high ED utilizers and frequent readmissions — exactly the populations payers want managed differently.

The tactical shift requires marketing to collaborate with care management and population health teams to identify patients before acute events occur. A heart failure patient discharged from your hospital should leave with printed materials, a magnet for their refrigerator, and a portal message about hospital-at-home as an alternative to ED visits during their next exacerbation. That's not a marketing campaign — it's patient education embedded in care transitions.

One more strategic consideration: hospital-at-home programs will face competition from non-health system entrants. Payers may contract directly with specialized home acute care vendors that operate no hospitals at all. Telehealth companies and home health agencies are expanding into acute care. Health systems that move first and build strong hospital-at-home brands will defend against these competitors. Health systems that wait will watch market share shift to organizations with no legacy facility costs and more agile operations.

The Takeaway